Differential effects of subtype-specific nicotinic acetylcholine receptor agonists on early and late hippocampal LTP

European Journal of Pharmacology

Volumn 671, Issue 1-3, 2011, Pages 26-32

  Kroker, Katja S ^a   Rast, Georg ^a   Rosenbrock, Holger ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

4 2 nAChR; 7 nAChR; Alzheimer's disease; Hippocampus; LTP; Nicotinic acetylcholine receptor agonist

Indexed keywords

1,4 DIAZABICYCLO[3.2.2]NONANE 4 CARBOXYLIC ACID 4 BROMOPHENYL ESTER; BUNGAROTOXIN RECEPTOR; N METHYL 5 (5 PYRIMIDINYL) 4 PENTEN 2 AMINE HEMIGALACTARATE; NICOTINIC AGENT; NICOTINIC RECEPTOR ALPHA4BETA2; TC 1827; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; HIPPOCAMPUS; LEARNING; LONG TERM POTENTIATION; MALE; MEMORY; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT;

ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; COGNITION; HIPPOCAMPUS; LONG-TERM POTENTIATION; MALE; NICOTINIC AGONISTS; RATS; RATS, WISTAR; RECEPTORS, NICOTINIC; SUBSTRATE SPECIFICITY; SUGAR ACIDS;

EID: 80455122692     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.09.167     Document Type: Article

References (97)

1. B.C. Albensi, D.R. Oliver, J. Toupin, and G. Odero Electrical stimulation protocols for hippocampal synaptic plasticity and neuronal hyper-excitability: are they effective or relevant? Exp. Neurol. 204 2007 1 13 (Pubitemid 46330292)
2. M. Alkondon, and E.X. Albuquerque The nicotinic acetylcholine receptor subtypes and their function in the hippocampus and cerebral cortex Prog. Brain Res. 145 2004 109 120 (Pubitemid 37442938)
3. M. Alkondon, E.F.R. Pereira, H.M. Eisenberg, and E.X. Albuquerque Choline and selective antagonists identify two subtypes of nicotinic acetylcholine receptors that modulate GABA release from CA1 interneurons in rat hippocampal slices J. Neurosci. 19 1999 2693 2705 (Pubitemid 29162417)
4. V.B. Aramakis, and R. Metherate Nicotine selectively enhances NMDA receptor-mediated synaptic transmission during postnatal development in sensory neocortex J. Neurosci. 18 1998 8485 8495 (Pubitemid 28465023)
5. S.P. Arneric, M. Holladay, and M. Williams Neuronal nicotinic receptors: a perspective on two decades of drug discovery research Biochem. Pharmacol. 74 2007 1092 1101 (Pubitemid 47417924)
6. S. Barak, M. Arad, A. De Levie, M.D. Black, G. Griebel, and I. Weiner Pro-cognitive and antipsychotic efficacy of the alpha7 nicotinic partial agonist SSR180711 in pharmacological and neurodevelopmental latent inhibition models of schizophrenia Neuropsychopharmacology 34 2009 1753 1763
7. Z.I. Bashir, S. Alford, S.N. Davies, A.D. Randall, and G.L. Collingridge Long-term potentiation of NMDA receptor-mediated synaptic transmission in the hippocampus Nature 349 1991 156 158 (Pubitemid 21912034)
8. B. Biton, O.E. Bergis, F. Galli, A. Nedelec, A.W. Lochead, S. Jegham, D. Godet, C. Lanneau, R. Santamaria, F. Chesney, J. Léonardon, P. Granger, M.W. Debono, G.A. Bohme, F. Sgard, F. Besnard, D. Graham, A. Coste, A. Oblin, O. Curet, X. Vigé, C. Voltz, L. Rouquier, J. Souilhac, V. Santucci, C. Gueudet, D. Françon, R. Steinberg, G. Griebel, F. Oury-Donat, P. George, P. Avenet, and B. Scatton SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (1) binding and functional profile Neuropsychopharmacology 32 2007 1 16 (Pubitemid 44967780)
9. T.V.P. Bliss, and G.L. Collingridge A synaptic model of memory: long-term potentiation in the hippocampus Nature 361 1993 31 39 (Pubitemid 23020772)
10. G.A. Bohme, S.R. Letchworth, O. Piot-Grosjean, G.J. Gatto, M.-C. Obinu, W.S. Caldwell, M. Laville, P. Brunel, R. Pellerin, J.P. Leconte, A. Genevois-Borella, P. Dubedat, M. Mazadier, L. Pradier, M. Bencherif, and J. Benavides In vitro and in vivo characterization of TC-1827, a novel brain α4β2 nicotinic receptor agonist with pro-cognitive activity Drug Dev. Res. 62 2004 26 40 (Pubitemid 39458699)
11. J.J. Buccafusco, J.W. Beach, A.V. Terry Jr., G.S. Doad, A. Sood, E. Arias, H. Misawa, M. Masai, T. Fujii, and K. Kawashima Novel analogs of choline as potential neuroprotective agents J. Alzheimer's Dis. 6 6 Suppl 2004 S85 S92
12. J.J. Buccafusco, S.R. Letchworth, M. Bencherif, and P.M. Lippiello Long-lasting cognitive improvement with nicotinic receptor agonists: mechanisms of pharmacokinetic-pharmacodynamic discordance Trends Pharmacol. Sci. 26 2005 352 360 (Pubitemid 40848496)
13. W.K. Chan, P.T. Wong, and F.S. Sheu Frontal cortical alpha7 and alpha4beta2 nicotinic acetylcholine receptors in working and reference memory Neuropharmacology 52 2007 1641 1649 (Pubitemid 46843139)
14. G.L. Collingridge, S.J. Kehl, and H. McLennan Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus J. Physiol. 334 1983 33 46 (Pubitemid 13176081)
15. C. Courtney, D. Farrell, R. Gray, R. Hills, L. Lynch, E. Sellwood, S. Edwards, W. Hardyman, J. Raftery, P. Crome, C. Lendon, H. Shaw, P. Bentham AD2000 Collaborative Group Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial Lancet 363 2004 2105 2115
16. M.W. Decker, J.D. Brioni, J.P. Sullivan, M.J. Buckley, R.J. Radek, J.L. Raszkiewicz, C.H. Kang, D.J.B. Kim, W.J. Giardina, J.T. Wasicak, D.S. Garvey, M. Williams, and S.P. Arneric (S)-3-methyl-5 (1-methyl-2-pyrrolidinyl)Isoxazole (ABT-418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization J. Pharmacol. Exp. Ther. 270 1994 319 328 (Pubitemid 24229642)
17. D. D'hoedt, and D. Bertrand Nicotinic acetylcholine receptors: an overview on drug discovery Expert Opin. Ther. Targets 13 2009 395 411
18. B.S. Diniz, J.A. Pinto Jr., M.L. Gonzaga, F.M. Guimarães, W.F. Gattaz, and O.V. Forlenza To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer's disease Eur. Arch. Psychiatry Clin. Neurosci. 259 2009 248 256
19. M. Dukat, and R.A. Glennon Epibatidine: impact on nicotinic receptor research Cell. Mol. Neurobiol. 23 2003 365 378 (Pubitemid 36681516)
20. F. Engert, and T. Bonhoeffer Dendritic spine changes associated with hippocampal long-term synaptic plasticity Nature 399 1999 66 70
21. R. Fabian-Fine, P. Skehel, M.L. Errington, H.A. Davies, E. Sher, M.G. Stewart, and A. Fine Ultrastructural distribution of the alpha7 nicotinic acetylcholine receptor subunit in rat hippocampus J. Neurosci. 21 2001 7993 8003 (Pubitemid 32952756)
22. C.M. Flores, S.W. Rogers, L.A. Pabreza, B.B. Wolfe, and K.J. Kellar A subtype of nicotinic cholinergic receptors in the rat brain is composed of a4 and b2 subunits and is up-regulated by chronic nicotine treatment Mol. Pharmacol. 41 1992 31 37
23. T. Frankiewicz, B. Potier, Z.I. Bashir, G.L. Collingridge, and C.G. Parsons Effects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices Br. J. Pharmacol. 117 1996 689 697 (Pubitemid 26070246)
24. R. Freedman, S. Leonard, J.M. Gault, J. Hopkins, C.R. Cloninger, C.A. Kaufmann, M.T. Tsuang, S.V. Farone, D.M. Svrakic, A. Sanders, and P. Gejam Linkage disequilibrium for schizophrenia at the chromosome 15q13-14 locus of the alpha7-nicotinic acetylcholine receptor subunit gene (CHRNA7) Am. J. Med. Genet. 105 2001 20 22
25. U. Frey, M. Krug, K.G. Reymann, and H. Matthies Anisomycin, an inhibitor of protein-synthesis, blocks late phase of LTP phenomena in the hippocampal CA1 region in vitro Brain Res. 452 1988 57 65
26. S. Ge, and J.A. Dani Nicotinic acetylcholine receptors at glutamate synapses facilitate long-term depression or potentiation J. Neurosci. 25 2005 6084 6091 (Pubitemid 40923475)
27. H. Geerts Ispronicline (Targacept) Curr. Opin. Invest. Drugs 7 2006 60 69
28. S. Graef, P. Schönknecht, O. Sabri, and U. Hegerl Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: an overview of preclinical and clinical findings Psychopharmacology (Berl) 215 2011 205 229
29. F. Grassi, E. Palma, R. Tonini, M. Amici, M. Ballivet, and F. Eusebi Amyloid beta(1-42) peptide alters the gating of human and mouse alpha-bungarotoxin-sensitive nicotinic receptors J. Physiol. 547 2003 147 157 (Pubitemid 36285170)
30. R. Gray, A.S. Rajan, K.A. Radcliffe, M. Yakehiro, and J.A. Dani Hippocampal synaptic transmission enhanced by low concentrations of nicotine Nature 83 1996 713 716 (Pubitemid 26360646)
31. V.P. Grinevich, R.L. Papke, P.M. Lippiello, and M. Bencherif Atypical antipsychotics as noncompetitive inhibitors of α4β2 and α7 neuronal nicotinic receptors Neuropharmacology 57 2009 183 191
32. M. Hajós, and B.N. Rogers Targeting alpha7 nicotinic acetylcholine receptors in the treatment of schizophrenia Curr. Pharm. Des. 16 2010 538 554
33. K. Hashimoto, T. Ishima, Y. Fujita, M. Matsuo, T. Kobashi, M. Takahagi, H. Tsukada, and M. Iyo Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the novel selective alpha7 nicotinic receptor agonist SSR180711 Biol. Psychiatry 63 2008 92 97 (Pubitemid 350234890)
34. T.A. Hauser, A. Kucinski, K.G. Jordan, G.J. Gatto, S.R. Wersinger, R.A. Hesse, E.K. Stachowiak, M.K. Stachowiak, R.L. Papke, P.M. Lippiello, and M. Bencherif TC-5619: an alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia Biochem. Pharmacol. 78 2009 803 812
35. S.N. Haydar, and J. Dunlop Neuronal nicotinic acetylcholine receptors - targets for the development of drugs to treat cognitive impairment associated with schizophrenia and Alzheimer's disease Curr. Top. Med. Chem. 10 2010 144 152
36. R. Helou, and M. Rhalimi Cholinesterase inhibitors and the risk of pulmonary disorders in hospitalized dementia patients J. Popul. Ther. Clin. Pharmacol. 17 2010 e379 e389
37. A.I. Herman, and M. Sofuoglu Cognitive effects of nicotine: genetic moderators Addict. Biol. 15 2010 250 265
38. R.K. Hernandez, W. Farwell, M.D. Cantor, and E.V. Lawler Cholinesterase inhibitors and incidence of bradycardia in patients with dementia in the veterans affairs new England healthcare system J. Am. Geriatr. Soc. 57 2009 1997 2003
39. M.W. Holladay, M.J. Dart, and J.K. Lynch Neuronal nicotinic receptors as targets for drug discovery J. Med. Chem. 40 1997 4169 4194 (Pubitemid 28042300)
40. E.P. Huang Synaptic plasticity: going through phases with LTP Curr. Biol. 8 1998 R350 R352
41. Y.-Y. Huang, and E.R. Kandel Recruitment of long-lasting and protein kinase A-dependent long-term potentiation in the CA1 region of hippocampus requires repeated tetanization Learn. Mem. 1 1994 74 82 (Pubitemid 2113963)
42. Y.-Y. Huang, P.V. Nguyen, T. Abel, and E.R. Kandel Long-lasting forms of synaptic potentiation in the mammalian hippocampus Learn. Mem. 3 1996 74 85 (Pubitemid 26357733)
43. D. Ji, and J.A. Dani Inhibition and disinhibition of pyramidal neurons by activation of nicotinic receptors on hippocampal interneurons J. Neurophysiol. 83 2000 2682 2690 (Pubitemid 30321461)
44. D. Ji, R. Lape, and J.A. Dani Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity Neuron 31 2001 131 141 (Pubitemid 32757094)
45. 2+ entry through non-alpha7 nicotinic acetylcholine receptors Eur. J. Neurosci. 31 2010 463 476
46. S. Jones, and J.L. Yakel Functional nicotinic ACh receptors on interneurones in the rat hippocampus J. Physiol. 504 1997 603 610 (Pubitemid 27493859)
47. S. Jones, S. Sudweeks, and J.L. Yakel Nicotinic receptors in the brain: correlating physiology with function Trends Neurosci. 22 1999 555 561
48. H. Kaduszkiewicz, T. Zimmermann, H.P. Beck-Bornholdt, and H. van den Bussche Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials BMJ 331 2005 321 327
49. 2+ regulation of nicotinic acetylcholine receptor channels in rat hippocampal CA1 neurons J. Neurosci. 23 2003 9024 9031 (Pubitemid 37243803)
50. S.E. Kristensen, M.S. Thomsen, H.H. Hansen, D.B. Timmermann, A. Hay-Schmidt, and J.D. Mikkelsen The alpha7 nicotinic receptor agonist SSR180711 increases activity regulated cytoskeleton protein (Arc) gene expression in the prefrontal cortex of the rat Neurosci. Lett. 418 2007 154 158 (Pubitemid 46635997)
51. K.S. Kroker, G. Rast, and H. Rosenbrock Differential effect of the mGlu5 receptor positive allosteric modulator ADX-47273 on early and late hippocampal LTP Neuropharmacology 61 2011 707 714
52. K.S. Kroker, H. Rosenbrock, and G. Rast A multi-slice recording system for stable late phase hippocampal long-term potentiation experiments J. Neurosci. Methods 194 2011 394 401
53. S.C. Leiser, M.R. Bowlby, T.A. Comery, and J. Dunlop A cog in cognition: how the alpha 7 nicotinic acetylcholine receptor is geared towards improving cognitive deficits Pharmacol. Ther. 122 2009 302 311
54. J. Lindstrom Nicotinic acetylcholine receptors in health and disease Mol. Neurobiol. 15 1997 193 222 (Pubitemid 127719578)
55. P. Lippiello, S.R. Letchworth, G.J. Gatto, V.M. Traina, and M. Bencherif Ispronicline: a novel alpha4beta2 nicotinic acetylcholine receptor-selective agonist with cognition-enhancing and neuroprotective properties J. Mol. Neurosci. 30 2006 19 20 (Pubitemid 46035302)
56. J. Lisman Actin's actions in LTP-induced synapse growth Neuron 38 2003 361 362 (Pubitemid 36579137)
57. G.K. Lloyd, and M. Williams Neuronal nicotinic acetylcholine receptors as novel drug targets J. Pharmacol. Exp. Ther. 292 2000 461 467 (Pubitemid 30067407)
58. Y. Lu, E.R. Kandel, and R.D. Hawkins Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus J. Neurosci. 19 1999 10250 10261 (Pubitemid 30228032)
59. L. Maggi, E. Sola, F. Minneci, C. Le Magueresse, J.P. Changeux, and E. Cherubini Persistent decrease in synaptic efficacy induced by nicotine at Schaffer collateral-CA1 synapses in the immature rat hippocampus J. Physiol. 559 2004 863 874 (Pubitemid 39276174)
60. R.C. Malenka, and R.A. Nicoll Long-term potentiation - a decade of progress? Science 285 1999 1870 1874
61. H.D. Mansvelder, and D.S. McGehee Long-term potentiation of excitatory inputs to brain reward areas by nicotine Neuron 27 2000 349 357
62. D.S. McGehee, M.J. Heath, S. Gelber, P. Devay, and L.W. Role Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors Science 269 1995 1692 1696
63. I. Melnikova Therapies for Alzheimer's disease Nat. Rev. Drug Discovery 6 2007 341 342 (Pubitemid 46696548)
64. G. Mudo, N. Belluardo, and K. Fuxe Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms J. Neural. Transm. 114 2007 135 147 (Pubitemid 46018681)
65. P.A. Newhouse, T. Sunderland, P.N. Tariot, C.L. Blumhardt, H. Weingartner, A. Mellow, and D.L. Murphy Intravenous nicotine in Alzheimer's disease: a pilot study Psychopharmacology 95 1988 171 175
66. P.V. Nguyen, and E.R. Kandel Brief theta-burst stimulation induces a transcription-dependent late phase of LTP requiring cAMP in area CA1 of the mouse hippocampus Learn. Mem. 4 1997 230 243 (Pubitemid 27350040)
67. P.V. Nguyen, T. Abel, and E.R. Kandel Requirement of a critical period of transcription for induction of a late phase of LTP Science 265 1994 1104 1107 (Pubitemid 24293080)
68. A. Nordberg Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications Biol. Psychiatry 49 2001 200 210 (Pubitemid 32178429)
69. P.T. Pang, and B. Lu Regulation of late-phase LTP and long-term memory in normal and aging hippocampus: role of secreted proteins tPA and BDNF Ageing Res. Rev. 3 2004 407 430 (Pubitemid 39487898)
70. D. Paterson, and A. Nordberg Neuronal nicotinic receptors in the human brain Prog. Neurobiol. 61 2000 75 111 (Pubitemid 30100404)
71. E.K. Perry, C.M. Martin-Ruiz, and J.A. Court Nicotinic receptor subtypes in human brain related to aging and dementia Alcohol 24 2001 63 68 (Pubitemid 32755908)
72. N.S. Philip, L.L. Carpenter, A.R. Tyrka, and L.H. Price Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature Psychopharmacology (Berl.) 212 2010 1 12
73. P. Pichat, O.E. Bergis, J.P. Terranova, A. Urani, C. Duarte, V. Santucci, C. Gueudet, C. Voltz, R. Steinberg, J. Stemmelin, F. Oury-Donat, P. Avenet, G. Griebel, and B. Scatton 80711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia Neuropsychopharmacology 32 2007 17 34 (Pubitemid 44967781)
74. V.I. Pidoplichko, J. Noguchi, O.O. Areola, Y. Liang, J. Peterson, T. Zhang, and J.A. Dani Nicotinic cholinergic synaptic mechanisms in the ventral tegmental area contribute to nicotine addiction Learn. Mem. 11 2004 60 69 (Pubitemid 38167059)
75. R.B. Poorthuis, N.A. Goriounova, J.J. Couey, and H.D. Mansvelder Nicotinic actions on neuronal networks for cognition: general principles and long-term consequences Biochem. Pharmacol. 78 2009 668 676
76. M. Quik, L.Z. Huang, N. Parameswaran, T. Bordia, C. Campos, and X.A. Perez Multiple roles for nicotine in Parkinson's disease Biochem. Pharmacol. 78 2009 677 685
77. K. Radcliffe, and J.A. Dani Nicotinic stimulation produces multiple forms of glutamatergic synaptic enhancement J. Neurosci. 18 1998 7075 7083 (Pubitemid 28425795)
78. R.J. Radek, K.L. Kohlhaas, L.E. Rueter, and E.G. Mohler Treating the cognitive deficits of schizophrenia with alpha4beta2 neuronal nicotinic receptor agonists Curr. Pharm. Des. 16 2010 309 322
79. K.G. Reymann, and J.U. Frey The late maintenance of hippocampal LTP: requirements, phases, 'synaptic tagging', 'late-associativity' and implications Neuropharmacology 52 2007 24 40
80. A.H. Rezvani, and E.D. Levin Cognitive effects of nicotine Biol. Psychiatry 49 2001 258 267 (Pubitemid 32178435)
81. L.W. Role, and D.K. Berg Nicotinic receptors in the development and modulation of CNS synapses Neuron 16 1996 1077 1085 (Pubitemid 26227229)
82. M.H. Rosenbloom, R. Finley, M.M. Scheinman, M.D. Feldman, B.L. Miller, and G.D. Rabinovici Donepezil-associated bradyarrhythmia in a patient with dementia with Lewy bodies (DLB) Alzheimer Dis. Assoc. Disord. 24 2010 209 211
83. L. Rozzini, D. Ghianda, M. Trabucchi, and A. Padovani Severe worsening of parkinsonism in Lewy body dementia due to donepezil Neurology 63 2004 1543 1544 (Pubitemid 39426311)
84. B. Sahakian, G. Jones, R. Levy, J. Gray, and D. Warburton The effects of nicotine on attention, information processing, and shortterm memory in patients with dementia of the Alzheimer type Br. J. Psychiatry 154 1989 797 800 (Pubitemid 19172212)
85. M. Sarter, V. Parikh, and W.M. Howe nAChR agonist-induced cognition enhancement: integration of cognitive and neuronal mechanisms Biochem. Pharmacol. 78 2009 658 667
86. A receptor benzodiazepine site ligands Neuropharmacology 36 1997 823 830 (Pubitemid 27286736)
87. P. Séguéla, J. Wadiche, K. Dineley-Miller, J.A. Dani, and J.W. Patrick Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium J. Neurosci. 13 1993 596 604 (Pubitemid 23045143)
88. P.A. St. John, and H. Gordon Agonists cause endocytosis of nicotinic acetylcholine receptors on cultured myotubes J. Neurobiol. 49 2001 212 223 (Pubitemid 33000767)
89. A. Taly, P.J. Corringer, D. Guedin, P. Lestage, and J.P. Changeux Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system Nat. Rev. Drug Discov. 8 2009 733 750
90. M.S. Thomsen, H.H. Hansen, D.B. Timmerman, and J.D. Mikkelsen Cognitive improvement by activation of alpha7 nicotinic acetylcholine receptors: from animal models to human pathophysiology Curr. Pharm. Des. 16 2010 323 343
91. J. Toyohara, and K. Hashimoto α7 nicotinic receptor agonists: potential therapeutic drugs for treatment of cognitive impairments in schizophrenia and Alzheimer's disease Open Med. Chem. J. 4 2010 37 56
92. E. Tribollet, D. Bertrand, A. Marguerat, and M. Raggenbass Comparative distribution of nicotinic receptor subtypes during development, adulthood and aging: an autoradiographic study in the rat brain Neuroscience 124 2004 405 420 (Pubitemid 38229660)
93. S. Vernino, M. Rogers, K.A. Radcliffe, and J.A. Dani Quantitative measurement of calcium flux through muscle and neuronal nicotinic acetylcholine receptors J. Neurosci. 14 1994 5514 5524 (Pubitemid 24279069)
94. T.L. Wallace, P.M. Callahan, A. Tehim, D. Bertrand, G. Tombaugh, S. Wang, W. Xie, W.B. Rowe, V. Ong, E. Graham, A.V. Terry Jr., J.S. Rodefer, B. Herbert, M. Murray, R. Porter, L. Santarelli, and D.A. Lowe RG3487, a novel nicotinic α7 receptor partial agonist, improves cognition and sensorimotor gating in rodents J. Pharmacol. Exp. Ther. 336 2011 242 253
95. A.L. Wilson, L.K. Langley, J. Monley, T. Bauer, S. Rottunda, E. McFalls, C. Kovera, and J.R. McCarten Nicotine patches in Alzheimer's disease: pilot study on learning, memory and safety Pharmacol. Biochem. Behav. 51 1995 509 514
96. S. Wonnacott Presynaptic nicotinic ACh receptors Trends Neurosci. 20 1997 92 98 (Pubitemid 27050704)
97. D.S. Woodruff-Pak, and T.J. Gould Neuronal nicotinic acetylcholine receptors: involvement in Alzheimer's disease and schizophrenia Behav. Cogn. Neurosci. Rev. 1 2002 5 20